Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
Cholinergic Antagonists: Pharmacokinetics01:24

Cholinergic Antagonists: Pharmacokinetics

Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations,  while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and the conjunctiva.
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance01:23

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Building bridges between brain and behavior: An open-source toolbox for joint modeling with fMRI.

Imaging neuroscience (Cambridge, Mass.)·2026
Same author

Trial-level sequence modeling reveals hidden dynamics of dual-task interference.

PLoS computational biology·2026
Same author

The Connection Between Associative Memory and Semantic Similarity: Evidence From Fan Experiments and Distributional Models.

Cognitive science·2026
Same author

Effector-specific corticospinal modulation is preserved in older adults during proactive stopping: A novel Bayesian approach.

Neurobiology of aging·2026
Same author

Adult learning of a novel quantifier tracks semantic universals.

Cognition·2026
Same author

Bayesian hierarchical cognitive modeling with the EMC2 package.

Behavior research methods·2026
Same journal

Synaptic micromechanics and brain softening as a mechanobiological hypothesis for Alzheimer's disease.

Frontiers in neuroscience·2026
Same journal

The relationship between healthy sleep patterns and the risk of scoliosis: a large prospective cohort study.

Frontiers in neuroscience·2026
Same journal

Dynamic functional reorganization in post-stroke aphasia: a state-of-the-art fMRI review from disease evolution to intervention.

Frontiers in neuroscience·2026
Same journal

Correction: Case Report: A possible novel adult-onset, progressive MAO-A hypofunction.

Frontiers in neuroscience·2026
Same journal

Respiratory modulation of neurophysiology and symptoms in athletes with sports-related concussion: a randomized crossover trial.

Frontiers in neuroscience·2026
Same journal

Impact of C-reactive protein-triglyceride-glucose and systemic immune-inflammation indices on obstructive sleep apnea in older adults with depression.

Frontiers in neuroscience·2026
See all related articles

Related Experiment Video

Updated: May 18, 2026

Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion
07:30

Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion

Published on: May 10, 2018

Bromocriptine does not alter speed-accuracy tradeoff.

Jasper Winkel1, Leendert van Maanen, Roger Ratcliff

  • 1Cognitive Science Center Amsterdam, University of Amsterdam Amsterdam, Netherlands.

Frontiers in Neuroscience
|September 13, 2012
PubMed
Summary
This summary is machine-generated.

Dopamine does not affect the speed-accuracy tradeoff in perceptual decision-making. This study found bromocriptine did not alter how quickly or accurately individuals made decisions.

Keywords:
bromocriptinedopaminedrift diffusion modelfunctional magnetic resonance imaginglinear ballistic accumulatormodel-based neuroimagingspeed–accuracy tradeoffstriatum

More Related Videos

The 5-Choice Serial Reaction Time Task: A Task of Attention and Impulse Control for Rodents
09:43

The 5-Choice Serial Reaction Time Task: A Task of Attention and Impulse Control for Rodents

Published on: August 10, 2014

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
07:02

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development

Published on: February 11, 2019

Related Experiment Videos

Last Updated: May 18, 2026

Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion
07:30

Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion

Published on: May 10, 2018

The 5-Choice Serial Reaction Time Task: A Task of Attention and Impulse Control for Rodents
09:43

The 5-Choice Serial Reaction Time Task: A Task of Attention and Impulse Control for Rodents

Published on: August 10, 2014

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
07:02

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development

Published on: February 11, 2019

Area of Science:

  • Neuroscience
  • Cognitive Science
  • Decision Science

Background:

  • The speed-accuracy tradeoff is a fundamental aspect of decision-making.
  • Dopamine is hypothesized to modulate this tradeoff, balancing fast versus accurate responses.

Purpose of the Study:

  • To investigate the role of dopamine in human perceptual decision-making, specifically its effect on the speed-accuracy tradeoff.
  • To examine whether bromocriptine, a dopamine receptor agonist, influences decision threshold and neural activity related to speed-accuracy adjustments.

Main Methods:

  • Utilized a cued random dot motion task where participants were instructed to prioritize speed or accuracy.
  • Administered bromocriptine or placebo to participants and analyzed behavioral data using drift diffusion and linear ballistic accumulator models.
  • Measured neural activity using fMRI, focusing on brain regions like the striatum and pre-supplementary motor area.

Main Results:

  • Behavioral analysis revealed significant differences in decision threshold based on speed versus accuracy instructions, but no difference between bromocriptine and placebo conditions.
  • Bayesian analyses supported the null hypothesis, indicating no effect of bromocriptine on decision threshold.
  • Neural data replicated previous findings of increased striatal and pre-supplementary motor area activation for speeded decisions, but bromocriptine did not modulate this activity.

Conclusions:

  • Bromocriptine does not alter the speed-accuracy tradeoff in perceptual decision-making in humans.
  • Dopamine modulation, at least via bromocriptine, does not appear to influence the behavioral or neural mechanisms underlying adjustments between speed and accuracy.